Trial · NCT03088878
Results by group63
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 63
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Response | MCL Phase 1b, Part 1: 2mg/kg | 3 | Participants | ||
| Overall Response | MCL Phase 1b, Part 1: 4mg/kg | 3 | Participants | ||
| Overall Response | MCL Phase 1b, Part 1: 8mg/kg | 3 | Participants | ||
| Overall Response | MCL Phase 1b, Part 1: 16 mg/kg | 2 | Participants | ||
| Overall Response | MCL Phase 1b, Part 2: 600 mg | 14 | Participants | ||
| Overall Response | CLL Phase 1b, Part 1: 2 mg/kg | 3 | Participants | ||
| Overall Response | CLL Phase 1b, Part 1: 4 mg/kg | 3 | Participants | ||
| Overall Response | CLL Phase 1b, Part 1: 8 mg/kg | 2 | Participants | ||
| Overall Response | CLL Phase 1b, Part 1: 16 mg/kg | 3 | Participants | ||
| Overall Response | CLL Phase 1b, Part 1: 300 mg | 3 | Participants | ||
| Overall Response | CLL Phase 1b, Part 1: 600 mg | 2 | Participants | ||
| Overall Response | CLL Phase 1b, Part 2: 600mg | 15 | Participants | ||
| Overall Response | CLL Phase 2, Part 3: 600 mg | 15 | Participants | ||
| Overall Response | CLL Phase 2, Part 3: Ibrutinib Alone | 7 | Participants | ||
| Progression Free Survival (PFS) | MCL Phase 1b, Part 1: 2mg/kg | NA | 95% Confidence Interval 35.9 to NA | months | |
| Progression Free Survival (PFS) | MCL Phase 1b, Part 1: 4mg/kg | NA | 95% Confidence Interval 16.5 to NA | months | |
| Progression Free Survival (PFS) | MCL Phase 1b, Part 1: 8mg/kg | 4.3 | 95% Confidence Interval 0.03 to NA | months | |
| Progression Free Survival (PFS) | MCL Phase 1b, Part 1: 16 mg/kg | NA | 95% Confidence Interval NA to NA | months | |
| Progression Free Survival (PFS) | MCL Phase 1b, Part 2: 600 mg | NA | 95% Confidence Interval NA to NA | months | |
| Progression Free Survival (PFS) | CLL Phase 1b, Part 1: 2 mg/kg | 36.3 | 95% Confidence Interval NA to NA | months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03088878/results